Stay updated on Atezolizumab vs Durvalumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab vs Durvalumab in NSCLC Clinical Trial page.

Latest updates to the Atezolizumab vs Durvalumab in NSCLC Clinical Trial page
- Check4 days agoChange DetectedThe page footer was updated to reflect a new ClinicalTrials.gov release revision, changing the displayed version from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check11 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded Abbotsford, British Columbia as a study location and updated the status to 'Results Submitted' while removing the previous 'No Results Posted' status.SummaryDifference0.0%

- Check33 days agoChange DetectedUpdated the Locations entry from Napoli, Campania, Italy, 80131 to Naples, Campania, Italy, 80131.SummaryDifference0.0%

- Check40 days agoChange DetectedThe site revision has been updated to v3.5.0, replacing v3.4.3.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.0%

Stay in the know with updates to Atezolizumab vs Durvalumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab vs Durvalumab in NSCLC Clinical Trial page.